INVERSAGO-PHARMA
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced today the dosing of the first participant with metabolic syndrome in a Phase 1b clinical trial.
This 28-day trial will test the pharmacokinetics and safety profile of Inversago’s lead molecule, INV-202, on a targeted population with metabolic syndrome. Topline results from 40 subjects are expected in the second half of the calendar year.
“We are pleased that the clinical trials for INV-202, our first-in-class, peripheral CB1 inhibitor, are moving ahead swiftly,” said Dr. François Ravenelle, Chief Executive Officer of Inversago. “This pharmacokinetic and safety study will also measure a number of well accepted biomarkers of metabolic disorders. Together, these results are expected to act as a guide for the next phase of INV-202’s development.”
Inversago is planning to launch its first Phase 2 study in patients with Diabetic Nephropathy (DN) shortly after results are available. DN involves a chronic loss of kidney function in people with type-1 and type-2 diabetes who also often present obesity. This patient profile allows for the objective measurement of primary endpoints specific to DN and secondary endpoints relevant to metabolic diseases at large. The company believes that this choice of indication provides the optimal proof of concept to demonstrate the therapeutic breadth of opportunity available to INV-202 and the rest of the Inversago pipeline.
Peripheral CB1 inverse agonists, such as Inversago’s lead INV-202 molecule, have demonstrated efficacy in addressing multiple pathways involved in renal injury. Aside effects on albuminuria in pre-clinical models, CB1 inverse agonists have shown clinical improvements in lipids, weight loss and glucose. Each of these effects have separately demonstrated reno-protective characteristics.
About Inversago Pharma
Located in Montreal, Inversago Pharma is a privately owned Canadian biotech company at clinical stage, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally acting CB1 inverse agonists. Inversago aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as Diabetic Nephropathy (DN), Non-Alcoholic Steatohepatitis (NASH), complications from obesity, Hypertriglyceridemia (HTG), Type 1 Diabetes (T1D) and Prader-Willi Syndrome (PWS), as well as fibrotic indications like Progressive Fibrosis-Interstitial Lung Disease (PF-ILD), including Idiopathic Pulmonary Fibrosis (IPF). For more information, visit inversago.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220315005525/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
European DataWarehouse Opens Bangalore Office20.5.2025 09:04:00 CEST | Press release
European DataWarehouse (EDW), Europe’s first securitisation repository, today announced the opening of a new office in Bangalore, India. This strategic expansion underscores EDW’s continued commitment to technological innovation and excellence in client service across global markets. The Bangalore office will serve as a center for IT operations, software development, and support for EDW’s flagship platforms, EDITOR and EDVANCE. It will also enable round-the-clock service for clients operating in non-European time zones and bring previously outsourced IT services in-house—enhancing security, responsiveness, and development agility. The new office will be led by Gopala Sankaran, Chief Technology Officer at European DataWarehouse, who joined the company in 2014 and brings extensive expertise in global tech strategy and development. Dr. Christian Thun, CEO of European DataWarehouse, commented: “Establishing a presence in India is an important and exciting step for EDW. Bangalore is home to
ActiveViam’s Atoti Powers SEB’s New P&L Sentinel for Streamlined Trading Desk Oversight20.5.2025 09:00:00 CEST | Press release
ActiveViam, a global provider of advanced data analytics and decision-making solutions for the Financial Services industry, announced today that SEB AB, the leading Nordic corporate bank, has implemented and rolled out Atoti, ActiveViam's flagship product, as their P&L reporting solution. Replacing a previous technology that was heavily based on spreadsheets and ad-hoc procedures, Atoti is now being used to investigate and report Actual P&L, create adjustments, and perform sign-off on aggregated P&L figures. The application called P&L Sentinel supports P&L Control and fifteen trading desks covering all traded assets of SEB. Atoti's multidimensional cubes together with its distributed data architecture, allows SEB to have on-the-fly access from the top of house to the most granular trade details with access to historical data within forty business days, as well as aggregated historical data by portfolio supporting MTD, QTD, and YTD calculations. Atoti Sign Off, a module in the Atoti pro
2025 Thales Data Threat Report Reveals Nearly 70% of Organizations Identify AI’s Fast-Moving Ecosystem as Top GenAI-Related Security Risk20.5.2025 09:00:00 CEST | Press release
73% are investing in AI-specific security tools with either new or existing budgets. Malware remains top attack type since 2021; phishing rises to second, ransomware drops to third. 60% identified future decryption of today’s data and future encryption compromise as major concerns among quantum computing security threats. Thales today announced the release of the 2025 Thales Data Threat Report, its annual report on the latest data security threats, trends, and emerging topics based on a survey conducted by S&P Global Market Intelligence 451 Research of more than 3,100 IT and security professionals in 20 countries across 15 industries. This year’s report found that nearly 70% of organizations view the rapid pace of AI development1 —particularly in generative AI—as the leading security concern related to its adoption, followed by lack of integrity (64%) and trustworthiness (57%). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20
IQM to Deliver World-leading 300-qubit Quantum Computer to Finland20.5.2025 08:45:00 CEST | Press release
IQM will deliver two IQM Radiance quantum computers to VTT in Finland: first a 150-qubit computer in 2026 and a 300-qubit computer in 2027. The 300-qubit system is powered by two superconducting 150-qubit quantum processors. The quantum computers will be specifically designed to serve as testbeds for quantum error correction (QEC) to enable research and development for fault-tolerant quantum computers. The two quantum computers will be integrated with the Finnish HPC infrastructure. IQM Quantum Computers, a global leader in superconducting quantum computers, announced today the signing of an agreement with VTT Technical Research Centre in Finland to deliver a 150-qubit and a 300-qubit quantum computer. The systems will be delivered in 2026 and 2027 and integrated with the Finnish HPC infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519294177/en/ IQM Radiance Quantum Computer The 300-qubit quantum computer is
Tecnotree Recognized in Gartner® Market Guide for CSP B2B Digital Marketplace Solutions20.5.2025 08:12:00 CEST | Press release
Tecnotree, a global digital platform and services leader for AI-enabled 5G and cloud-native technologies, has been named a Representative Vendor in the 2025 Gartner® Market Guide for CSP B2B Digital Marketplace Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519187602/en/ Tecnotree Recognized in Gartner® Market Guide for CSP B2B Digital Marketplace Solutions The report highlights the strategic role of digital marketplaces in helping communications service providers (CSPs) diversify revenue streams, strengthen enterprise relationships, and lead ecosystem-driven innovation. According to Gartner, “By 2028, 60% of Tier 1 CSPs will utilize digital marketplaces to serve B2B customers, a substantial increase from around 25% today.” As per our understanding, this shift reflects a growing need for CSPs to evolve beyond traditional connectivity and offer integrated, value-added solutions through agile partner ecosystems.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom